Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ACTINIUM PHARMACEUTICALS, INC.

(ATNM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about ACTINIUM PHARMACEUTICALS, INC.
09/23ACTINIUM PHARMACEUTICALS : Announces Multiple Senior Leadership Appointments Including Chi..
PU
09/23ACTINIUM PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Regulation FD ..
AQ
09/23Actinium Announces Multiple Senior Leadership Appointments Including Chief Business and..
CI
09/23ACTINIUM PHARMACEUTICALS RALLY INTAC : Atnm)
AQ
09/21ACTINIUM PHARMACEUTICALS STOCK JUMPS : Atnm)
AQ
09/20ACTINIUM PHARMACEUTICALS, INC.(NYSEA : ATNM) added to S&P Global BMI Index
CI
09/16ACTINIUM PHARMACEUTICALS : Completes Enrollment in the Pivotal Phase 3 SIERRA Trial of Iom..
AQ
09/15ACTINIUM PHARMACEUTICALS : Completes Enrollment in Phase 3 Trial of Iomab-B to Treat Leuke..
MT
09/15Actinium Pharmaceuticals, Inc. Completes Enrollment in the Pivotal Phase 3 SIERRA Trial..
CI
08/03ACTINIUM PHARMACEUTICALS : HC Wainwright Adjusts Actinium Pharmaceuticals' Price Target to..
MT
07/30ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
07/30Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended Ju..
CI
06/29ACTINIUM PHARMACEUTICALS : Announces Inclusion in Russell Microcap Index
AQ
06/17ACTINIUM PHARMACEUTICALS : Awarded Patents in Europe, Japan for Antibody Radiation Conjuga..
MT
06/15Actinium Pharmaceuticals, Inc. Announces Safety Data from Phase 3 SIERRA Trial of Iomab..
CI
06/04ACTINIUM PHARMACEUTICALS : Announces Several Presentations from the Phase 3 SIERRA Study o..
AQ
06/03Actinium Pharmaceuticals, Inc. Announces Several Presentations from the Phase 3 SIERRA ..
CI
05/14ACTINIUM : Q1 Earnings Snapshot
AQ
05/14ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
05/14Actinium Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended Mar..
CI
04/01ACTINIUM PHARMACEUTICALS : HC Wainwright Adjusts Price Target on Actinium Pharmaceuticals ..
MT
04/01ACTINIUM PHARMACEUTICALS : to Participate in the Cell & Gene Meeting on the Mediterranean
AQ
03/31ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
03/31Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended Decembe..
CI
03/26ACTINIUM PHARMACEUTICALS : Announces Completion of Enrollment of Second Dose Cohort in Act..
AQ
03/25ACTINIUM PHARMACEUTICALS : Announces Initiation of Patient Enrollment in Iomab-ACT Trial f..
AQ
03/25ACTINIUM PHARMACEUTICALS : Completes Enrollment of Second Dose Cohort of Actimab-A Venetoc..
MT
03/25Actinium Pharmaceuticals, Inc. Announces Completion of Enrollment of Second Dose Cohort..
CI
03/24ACTINIUM PHARMACEUTICALS : Begins Patient Enrollment for Iomab-ACT Study to Treat Leukemia..
MT
03/24Actinium Pharmaceuticals, Inc. Announces Initiation of Patient Enrollment in Iomab-ACT ..
CI
03/12ACTINIUM PHARMACEUTICALS : to Highlight Expansion of Targeted Conditioning Portfolio at AA..
AQ
03/11Actinium to Highlight Expansion of Targeted Conditioning Portfolio at AACR with Next-Ge..
CI
03/04ACTINIUM PHARMACEUTICALS : Announces Appointment of Mark Kubik, MBA as Chief Business Offi..
AQ
03/03ACTINIUM PHARMACEUTICALS : Announces Participation in H.C. Wainwright Global Life Sciences..
AQ
03/03ACTINIUM PHARMACEUTICALS : Names Mark Kubik as Chief Business Officer
MT
03/03Actinium Pharmaceuticals, Inc. Appoints Mark Kubik as Chief Business Officer
CI
02/11ACTINIUM PHARMACEUTICALS : Safety Results with Targeted Conditioning via Iomab-B
PU
02/11ACTINIUM PHARMACEUTICALS : Announces Participation in BIO CEO and Investor Digital Confere..
AQ
02/11Actinium Showcases Targeted Conditioning Program with 2 Oral Presentations Highlighting..
CI
01/21ACTINIUM PHARMACEUTICALS : to Participate in a Fireside Chat at the B. Riley Oncology Inve..
AQ
01/14ACTINIUM PHARMACEUTICALS : and Astellas Announce Research Collaboration Focused on Novel -..
AQ
2020ACTINIUM PHARMACEUTICALS : Announces Successful Pre-Planned Ad Hoc Interim Analysis of Pha..
AQ
2020ACTINIUM PHARMACEUTICALS : Says Committee Recommends Continuation of Late-Stage Study of L..
MT
2020Actinium Announces Successful Pre-Planned Ad Hoc Interim Analysis of Phase 3 SIERRA Tri..
CI
2020ACTINIUM PHARMACEUTICALS : Highlights Presence at Targeted Radiopharmaceuticals Summit
AQ
2020ACTINIUM PHARMACEUTICALS : Reports 67 Percent Overall Response Rate in First Cohort in Act..
AQ
2020Actinium Pharmaceuticals, Inc. Reports 67% Overall Response Rate in First Cohort in Act..
CI
2020Actinium Pharmaceuticals, Inc. Announces Positive Interim Results from Iomab-B Pivotal ..
CI
2020Actinium Pharmaceuticals, Inc. Announces Safety Data from its Ongoing Pivotal Phase 3 S..
CI
2020Actinium Pharmaceuticals, Inc. Presents Interim Data from Actimab-A CLAG-M Phase 1 Comb..
CI
2020ACTINIUM PHARMACEUTICALS : Highlights Clinical Data to be presented at the Upcoming 62nd A..
AQ
2020ACTINIUM PHARMACEUTICALS : Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinic..
AQ
2020ACTINIUM PHARMACEUTICALS : Highlights Foundational Patents Covering the Composition of Apa..
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Submission of ..
AQ
2020ACTINIUM PHARMACEUTICALS : Strengthens Leadership Team with Appointment of Dr. Avinash Des..
AQ
2020Actinium Pharmaceuticals, Inc. Appoints Avinash Desai as Executive Vice President of Cl..
CI
2020ACTINIUM PHARMACEUTICALS : to Participate in the Alliance Global Partners Virtual Healthca..
AQ
2020ACTINIUM PHARMACEUTICALS : Investor Presentation
PU
2020ACTINIUM PHARMACEUTICALS : Alliance Global Starts Actinium Pharmaceuticals at Buy With $25..
MT
2020ACTINIUM PHARMACEUTICALS : Reports 100% Remission Rate in Cohort of Phase 1 Study of Actim..
MT
2020Actinium Pharmaceuticals, Inc. Announces 100% Remission Rate Reported in Third Dose Coh..
CI
2020Actinium Pharmaceuticals, Inc. Announces Actimab-A Venetoclax First-In-Human Data Accep..
CI
2020ACTINIUM PHARMACEUTICALS : Letter to Shareholders
PU
2020ACTINIUM PHARMACEUTICALS : Provides Corporate Update and Year-End 2020 Outlook
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibi..
AQ
2020ACTINIUM PHARMACEUTICALS : Investor Presentation
PU
2020ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
2020Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter Ended Sep..
CI
2020ACTINIUM PHARMACEUTICALS : Investor Presentation
PU
2020ACTINIUM PHARMACEUTICALS : Awarded Grant by National Institutes of Health to Study Novel I..
AQ
2020Actinium Pharmaceuticals, Inc. Receives Grant by National Institutes of Health to Study..
CI
2020ACTINIUM PHARMACEUTICALS : Expands R&D Capabilities with New Research Facility to Enhance ..
AQ
2020Actinium Pharmaceuticals, Inc. Expands R&D Capabilities with New Research Facility to E..
CI
2020Actinium Pharmaceuticals, Inc. Announces Clinical Trial Site Expansion in Its Multi-Cen..
CI
2020ACTINIUM PHARMACEUTICALS : Successfully Completes First Dosing Cohort in the Phase 1 Study..
AQ
1  2  3  4  5Next